Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept in De Novo Heart Transplantation - Pilot Study
NCT04477629Phase 2Recruiting
- Sponsor
- NYU Langone Health
- Start
- Aug 2020
- Primary completion
- Sep 2026
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in heart transplant rejection, sponsored by NYU Langone Health. Started Aug 2020; status: recruiting.
02
Drugs
belatacept
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT04477629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04477629.